Rearrangements including NTRK1, NTRK2, and NTRK3 are in approximately 2–3% NSCLC patients without other driving genes, such as EGFR, KRAS, EML4-ALK, and ROS1 (Ricciuti et al., 2017). The gene discussed is ROS1; the disease is non-small cell lung carcinoma.